Trabectedin

Grey

Brand Name(s):Yondelis

Indication:Relapsed platinum-sensitive ovarian cancer.

Rationale:1

Considered:May-11

Review Date:May-21

Comments:
NICE TA389 Ovarian cancer – recurrent
Apr-16
…………………………
1.1 Trabectedin in combination with pegylated liposomal doxorubicin hydrochloride (PLDH) is not recommended for the treatment of women with relapsed platinum-sensitive ovarian cancer.
1.2 Women with relapsed platinum-sensitive ovarian cancer currently receiving trabectedin plus PLDH should have the option to continue treatment until they and their clinicians consider it appropriate to stop.

NICE Guidance TA222 Ovarian cancer (relapsed) – trabectedin 21st April 2011